Clinical Commissioning Policy: Lomitapide for treating homozygous familial hypercholesterolaemia (adults)

Document first published:: 6 July 2018
Page updated:: 6 July 2018
Topic:: Commissioning, Specialised commissioning
Publication type:: Policy or strategy

This policy document outlines the arrangements for funding of treatment for homozygous familial hypercholesterolaemia.

Document

Clinical Commissioning Policy: Lomitapide for treating homozygous familial hypercholesterolaemia (adults)

Clinical Commissioning Policy: Lomitapide for treating homozygous familial hypercholesterolaemia (adults)

PDF
398 KB
24 pages